(Q36897167)

16 August 2017

title

CDP840: a novel inhibitor of PDE-4. (English)

1 reference

16 August 2017

Perry MJ

1

1 reference

16 August 2017

O'Connell J

2

1 reference

16 August 2017

Walker C

3

1 reference

16 August 2017

Crabbe T

4

1 reference

16 August 2017

Baldock D

5

1 reference

16 August 2017

Russell A

6

1 reference

16 August 2017

Lumb S

7

1 reference

16 August 2017

Huang Z

8

1 reference

16 August 2017

Howat D

9

1 reference

16 August 2017

Allen R

10

1 reference

16 August 2017

Merriman M

11

1 reference

16 August 2017

Walls J

12

1 reference

16 August 2017

Daniel T

13

1 reference

16 August 2017

Hughes B

14

1 reference

16 August 2017

Laliberte F

15

1 reference

16 August 2017

Higgs GA

16

1 reference

16 August 2017

Owens RJ

17

1 reference

16 August 2017

publication date

1 January 1998

1 reference

Cell Biochemistry and Biophysics

16 August 2017

published in

1 reference

16 August 2017

volume

29

1 reference

16 August 2017

issue

1-2

1 reference

16 August 2017

page(s)

113-132

1 reference

A family of human phosphodiesterases homologous to the dunce learning and memory gene product of Drosophila melanogaster are potential targets for antidepressant drugs

16 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

The human cyclic AMP-specific phosphodiesterase PDE-46 (HSPDE4A4B) expressed in transfected COS7 cells occurs as both particulate and cytosolic species that exhibit distinct kinetics of inhibition by the antidepressant rolipram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

Phosphorylation and activation of a cAMP-specific phosphodiesterase by the cAMP-dependent protein kinase. Involvement of serine 54 in the enzyme activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP840, a novel stereo-selective inhibitor of phosphodiesterase type 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

The determination of enzyme inhibitor constants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP‐specific phosphodiesterase: comparison with rolipram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

Purification, characterization and analysis of rolipram inhibition of a human type-IVA cyclic AMP-specific phosphodiesterase expressed in yeast

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

Inhibition of bronchospasm and ozone-induced airway hyperresponsiveness in the guinea-pig by CDP840, a novel phosphodiesterase type 4 inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

Effect of the glucocorticosteroid budesonide and a novel phosphodiesterase type 4 inhibitor CDP840 on antigen-induced airway responses in neonatally immunised rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02737831

21 January 2018

Identifiers

DOI

10.1007/BF02737831

1 reference

16 August 2017

1 reference